Abstract

Phospholipase D3 (PLD3) polymorphisms are linked to late-onset Alzheimer’s disease (LOAD). Being a lysosomal 5’-3’ exonuclease, its neuronal substrates remained unknown as well as how a defective lysosomal nucleotide catabolism connects to AD-proteinopathy. We identified mitochondrial DNA (mtDNA) as a major physiological substrate and show its manifest build-up in lysosomes of PLD3-defective cells. mtDNA accretion creates a degradative (proteolytic) bottleneck that presents at the ultrastructural level as a marked abundance of multilamellar bodies, often containing mitochondrial remnants, which correlates with increased PINK1-dependent mitophagy. Lysosomal leakage of mtDNA to the cytosol activates cGAS–STING signaling that upregulates autophagy and induces amyloid precursor C-terminal fragment (APP-CTF) and cholesterol accumulation. STING inhibition largely normalizes APP-CTF levels, whereas an APP knockout in PLD3-deficient backgrounds lowers STING activation and normalizes cholesterol biosynthesis. Collectively, we demonstrate molecular cross-talks through feedforward loops between lysosomal nucleotide turnover, cGAS-STING and APP metabolism that, when dysregulated, result in neuronal endolysosomal demise as observed in LOAD.

Phospholipase D3 polymorphisms are linked to late-onset Alzheimer’s disease but the mechanisms are not understood. Van Acker and colleagues show that Phospholipase D3 processes mitochondrial DNA in lysosomes to maintain lysosomal homeostasis and proper degradation of the amyloid precursor protein.

Details

Title
Phospholipase D3 degrades mitochondrial DNA to regulate nucleotide signaling and APP metabolism
Author
Van Acker, Zoë P. 1   VIAFID ORCID Logo  ; Perdok, Anika 1   VIAFID ORCID Logo  ; Hellemans, Ruben 1   VIAFID ORCID Logo  ; North, Katherine 1   VIAFID ORCID Logo  ; Vorsters, Inge 1   VIAFID ORCID Logo  ; Cappel, Cedric 2 ; Dehairs, Jonas 3   VIAFID ORCID Logo  ; Swinnen, Johannes V. 3   VIAFID ORCID Logo  ; Sannerud, Ragna 1   VIAFID ORCID Logo  ; Bretou, Marine 1   VIAFID ORCID Logo  ; Damme, Markus 2   VIAFID ORCID Logo  ; Annaert, Wim 1 

 VIB Center for Brain & Disease Research, Laboratory for Membrane Trafficking, Leuven, Belgium (GRID:grid.511015.1); KU Leuven, Department of Neurosciences, Leuven, Belgium (GRID:grid.5596.f) (ISNI:0000 0001 0668 7884) 
 Christian-Albrechts-University Kiel, Laboratory for Molecular Cell Biology and Transgenic Research, Institute of Biochemistry, Kiel, Germany (GRID:grid.9764.c) (ISNI:0000 0001 2153 9986) 
 KU Leuven, Laboratory of Lipid Metabolism & Cancer, Department of Oncology, Leuven, Belgium (GRID:grid.5596.f) (ISNI:0000 0001 0668 7884) 
Pages
2847
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2818591813
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.